High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients.

[1]  D. Correa,et al.  Delayed neurotoxicity in primary central nervous system lymphoma. , 2005, Archives of neurology.

[2]  J. Benedet,et al.  Gestational trophoblastic neoplasia, FIGO 2000 staging and classification , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[3]  R. Soffietti,et al.  Management of brain metastases , 2002, Journal of Neurology.

[4]  G. Rustin,et al.  Management of brain metastases in patients with high-risk gestational trophoblastic tumors. , 2002, The Journal of reproductive medicine.

[5]  J. Doroshow,et al.  Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis , 2000, Cancer Chemotherapy and Pharmacology.

[6]  R. Coleman,et al.  Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role? , 1999, British Journal of Cancer.

[7]  J. Blay,et al.  High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  B. Mychalczak,et al.  Prognosis of patients treated with whole-brain radiation therapy for metastatic gestational trophoblastic disease. , 1998, Gynecologic oncology.

[9]  W. Small,et al.  Gestational trophoblastic disease metastatic to the brain. , 1996, Radiology.

[10]  E. Newlands,et al.  Gestational choriocarcinoma metastatic to the brain treated successfully by stereotactic radiosurgery and chemotherapy. , 1996, Clinical oncology (Royal College of Radiologists (Great Britain)).

[11]  A. Berchuck,et al.  Gestational trophoblastic disease metastatic to the central nervous system. , 1995, Gynecologic oncology.

[12]  A. Karim Stereotactic irradiations on the horizon: a challenge for multimodal developments. , 1994, International journal of radiation oncology, biology, physics.

[13]  A. Berchuck,et al.  Alternating weekly chemotherapy with etoposide‐methotrexatedactinomycin/cyclophosphamide‐vincristine for high‐risk gestational trophoblastic disease , 1994, Obstetrics and gynecology.

[14]  B. O'neill,et al.  Delayed leukoencephalopathy in survivors with small cell lung cancer , 1987, Neurology.